Literature DB >> 8979479

Anti-ulcerogenic activity of GABA and GABA mimetic agents in rats.

R K Goel1, W R Abbas, R N Maiti, S K Bhattacharya.   

Abstract

To elucidate the involvement of peripheral gamma- aminobutyric acid (GABA) and some GABA-mimetic agents in different models of gastric and duodenal ulcerations in rats and guinea pigs, effects of GABA, baclofen (GABAB agonist), diazepam, gamma-butyrolactone (GABA receptor agonist), sodium valproate, isoniazid (GABA-T inhibitor) and glycine (an inhibitory neurotransmitter), given po or ip were studied. All the drugs significantly reduced the ulcer index, incidence and number of ulcer in various models of gastric ulcers except glycine which failed to protect in reserpine-induced ulcers in rats. None of the drugs, except diazepam, had any protective effect on histamine-induced gastric ulcers in guinea pigs. Similarly, no protection was observed by any drug against cysteamine-induced duodenal ulcers in rats, while sodium valproate, isoniazid and glycine significantly decreased number of ulcers against histamine-induced duodenal ulcer in guinea pigs. The results suggest that GABA and GABA-mimetic agents, and glycine, an inhibitory neurotransmitter, afforded protection against some experimental models of peptic ulcer in rats. The effects appear to be due to their inhibitory effect on mucosal defensive factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8979479

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  2 in total

1.  GABAergic mechanisms of gastroprotection in the rat: role of sensory neurons, prostaglandins, and nitric oxide.

Authors:  Richard F Harty; Hanumantha R Ancha; Yang Xia; Mark Anderson; Ahmad Jazzar
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

2.  Evaluation of behavioural and antioxidant activity of Cytisus scoparius Link in rats exposed to chronic unpredictable mild stress.

Authors:  Jayabalan Nirmal; Chidambaram Saravana Babu; Thanukrishnan Harisudhan; Muthiah Ramanathan
Journal:  BMC Complement Altern Med       Date:  2008-04-24       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.